While the major market averages languished in November, precious metals soared. The trend is evident in the list of the month's best-performing open-end stock mutual funds. Nine of the 10 top-performing open-end stock mutual funds -- as calculated by TheStreet.com Ratings from Oct. 31 to Nov. 28 -- focused on precious metals investments. In November, the spot price of silver rose 4.6% to $10.30 an ounce, platinum climbed 7.1% to $881.50, and gold gained 12.9% to $818.05. And as the Philadelphia Gold & Silver Index climbed 25.58% that month, the 150% leveraged ProFunds Precious Metals UltraSector ProFund ( PMPIX - Get Report) made the most of the bounce in prices. Index member standouts in the period were Agnico-Eagle Mines ( AEM, up 36.20%; Barrick Gold ( ABX, up 30.49%; and Goldcorp ( GG - Get Report); up 44.65%. However, one non-metals fund topped the other nine metals funds. The Monteagle Informed Investor Growth Fund ( MIIFX - Get Report) is a new fund with $6.96 billion in assets. The funds's 36.73% rise helped it to regain back much of its losses since its April 4 inception. Four of Monteagle's five largest holdings are inverse, or short, exchange-traded funds that are 200% leveraged. They include ProShares UltraShort Oil & Gas ( DUG, ProShares UltraShort Russell2000 ( TWN, ProShares UltraShort QQQ ( QID - Get Report) and ProShares UltraShort S&P500 ( SDS. On the bullish side of Monteagle's equation is a 40.6% allocation to biotechnology stocks, led by Myriad Genetics ( MYGN, Genentech ( DNA and Amgen ( AMGN.
For more information, check out an explanation of our ratings.